News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • SK hynix pitched as a tactical long to capture AI server memory demand via NAND and DRAM integration.
  • TransMedics upgraded to a patient long ahead of multiple 2027 clinical and commercial catalysts.
  • TransMedics Q2 revenue rose 20.7% year‑over‑year, with reinvestment compressing near‑term margins.
  • LB Pharmaceuticals flagged as a conviction long with buyable pullback in the low $40s and a $35 hard stop.
  • LB's NOVA‑2 Phase 3 topline moved into H1 2027 while management says cash runway extends through Q2 2029.

Latest Articles

25 Democratic-Led States File Suit Over Latest U.S. Tariffs

25 Democratic-Led States File Suit Over Latest U.S. Tariffs

On Aug 3, a coalition of 25 Democratic-led U.S. states filed a lawsuit in the U.S. Court of International Trade in New York, contesting the Trump administration's July 24 imposition of new tariffs on goods from 60 trading partners. The suit, announced by the Oregon Attorney General's office, follows separate legal challenges from small U.S. busines…

California Supreme Court Rejects 'Duty to Innovate' Claim in Favor of Gilead

California Supreme Court Rejects 'Duty to Innovate' Claim in Favor of Gilead

The California Supreme Court, in a 6-1 ruling, dismissed negligence claims from roughly 24,000 HIV patients against Gilead Sciences over the company’s decision two decades ago to stop developing an alternative formulation. The court held that imposing a legal 'duty to innovate' would force juries to second-guess scientific decisions and could harm …

Five Large-Cap U.S. Stocks Trading Well Below Graham Intrinsic Value

Five Large-Cap U.S. Stocks Trading Well Below Graham Intrinsic Value

Five sizable U.S.-listed companies are trading at steep discounts to values calculated using Ben Graham’s intrinsic value formula. Each name meets Graham’s traditional thresholds of P/E ≤ 15 and P/B ≤ 1.5, producing theoretical upside ranges from about +99% to +216% relative to Graham values, though the market’s discount reflects concerns about ear…

First Solar Shares Jump as Analysts Lift Targets After Strong Q2 Beat

First Solar Shares Jump as Analysts Lift Targets After Strong Q2 Beat

First Solar rallied more than 11% in afternoon trading after reporting a quarter that exceeded analyst expectations and prompting several price-target increases. The company posted Q2 earnings per share of $3.92, net income that rose about 24% year-over-year to roughly $423 million, and disclosed a contracted backlog of 45.1 GW valued at $13.6 bill…

Boeing and the Recovery in Deliveries: Time to Lean Into the Upside

Boeing and the Recovery in Deliveries: Time to Lean Into the Upside

Boeing's production cadence is stabilizing and deliveries are accelerating. With fresh commercial leases, a multi-billion defense satellite award, and improving technical momentum, the risk/ reward favors a long exposure into the next 6 months. This is a trade idea — entry, stop, and target defined — built around improving fundamentals and a re-rat…

Micron: The Market Is Punishing the Wrong Math — Upgrade to Buy

Micron: The Market Is Punishing the Wrong Math — Upgrade to Buy

Micron is trading like a cyclical commodity stock in a panic while delivering exceptional profitability, cash flow and shareholder-friendly metrics. At $825, the company trades at ~18x trailing earnings with $26.2B in free cash flow and an enterprise value roughly in line with market cap. This trade idea upgrades Micron to a BUY with a clear entry,…

Fed Survey Finds C&I Standards Largely Unchanged as Consumer Credit Mix Shifts

Fed Survey Finds C&I Standards Largely Unchanged as Consumer Credit Mix Shifts

A Federal Reserve Senior Loan Officer Survey for July reported largely unchanged lending standards for commercial and industrial (C&I) loans during roughly the second quarter, while demand patterns diverged across firm sizes and consumer loan types. Banks cited stronger C&I loan demand from large and middle market firms, mixed lending standards for…

Apple Challenges UK Demand Over Encrypted Cloud Backups

Apple Challenges UK Demand Over Encrypted Cloud Backups

Apple has lodged a legal complaint with Britain’s Investigatory Powers Tribunal to contest a requirement that it enable access to encrypted cloud backups from UK users. The move follows a withdrawn mandate that previously would have covered both UK and U.S. customers and a later notice that reportedly excludes U.S. users. UK officials declined to c…

Oracle Shares Jump as Gemini AI Models Are Integrated Into Enterprise Suite

Oracle Shares Jump as Gemini AI Models Are Integrated Into Enterprise Suite

Oracle shares climbed sharply in afternoon trading after the company deepened an AI alliance with Google Cloud that embeds Gemini models into Oracle’s enterprise applications, while broader market relief tied to a de-escalation in geopolitical tensions reinforced gains. Analyst sentiment remains bullish and a recent multi-year Pentagon contract add…